Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development oftargeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.
